Miriam Kim, MD

Medical School Department Internal Medicine
Research Program Hematopoietic Development & Malignancy
Miriam Kim

Researcher Background

Primary Academic Title

Assistant Professor of Medicine, Division of Oncology, WashU Medicine

Training

  • 2008 - 2011: Resident, Internal Medicine, SUNY Downstate Medical Center, Brooklyn, NY
  • 2011 - 2014: Fellow, Hematology and Oncology, University of Southern California, Los Angeles, CA
  • 2014 - 2017: Postdoctoral Researcher, University of Pennsylvania, Philadelphia, PA

Education

  • 2008: MD, Seoul National University, South Korea

Research & Selected Publications

Research Interest

Developing genetically modified T cells for therapy of acute myeloid leukemia

Research Publications

Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activity.
Authors:

Thomas R, Ritchey JK, DiPersio JF, Kim MY

Journal & Year:

Mol Ther • 2025

Making normal hematopoiesis invisible to CAR T cells.
Authors:

Kim MY

Journal & Year:

Trends Cancer • 2023

An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies.
Authors:

Xiang J, Devenport JM, Carter AJ, one or more additional authors omitted Kim MY, one or more additional authors omitted DiPersio JF

Journal & Year:

Leukemia • 2023